KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Acquisitions (2016 - 2025)

Evolent Health has reported Acquisitions over the past 11 years, most recently at $1.4 million for Q4 2025.

  • Quarterly results put Acquisitions at $1.4 million for Q4 2025, down 89.85% from a year ago — trailing twelve months through Dec 2025 was $57.4 million (up 86.96% YoY), and the annual figure for FY2025 was $57.4 million, up 86.96%.
  • Acquisitions for Q4 2025 was $1.4 million at Evolent Health, up from -$2000.0 in the prior quarter.
  • Over the last five years, Acquisitions for EVH hit a ceiling of $386.7 million in Q1 2023 and a floor of -$2000.0 in Q3 2025.
  • Median Acquisitions over the past 5 years was $4.5 million (2025), compared with a mean of $45.5 million.
  • Biggest five-year swings in Acquisitions: soared 552362.86% in 2023 and later plummeted 100.02% in 2025.
  • Evolent Health's Acquisitions stood at $47.1 million in 2021, then tumbled by 93.44% to $3.1 million in 2022, then crashed by 50.74% to $1.5 million in 2023, then surged by 805.26% to $13.8 million in 2024, then plummeted by 89.85% to $1.4 million in 2025.
  • The last three reported values for Acquisitions were $1.4 million (Q4 2025), -$2000.0 (Q3 2025), and $51.5 million (Q2 2025) per Business Quant data.